Similar articles

• Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

  Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Migliori GB, et al. Eur Respir J. 2008 Apr;31(4):904-5. doi: 10.1183/09031936.00159807. Eur Respir J. 2008. PMID: 18378786 No abstract available.
• Fluoroquinolone Preventive Therapy after Exposure to Multidrug-Resistant Tuberculosis? Hopes and Fears.

  Bothamley GH. Bothamley GH. Am J Respir Crit Care Med. 2015 Jul 15;192(2):131-2. doi: 10.1164/rccm.201505-0863ED. Am J Respir Crit Care Med. 2015. PMID: 26177170 No abstract available.
• Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.

  Aung KJ, Van Deun A, Declercq E, Sarker MR, Das PK, Hossain MA, Rieder HL. Aung KJ, et al. Int J Tuberc Lung Dis. 2014 Oct;18(10):1180-7. doi: 10.5588/ijtld.14.0100. Int J Tuberc Lung Dis. 2014. PMID: 25216831
• Fluoroquinolones for the treatment of pulmonary tuberculosis.

  Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F. Moadebi S, et al. Drugs. 2007;67(14):2077-99. doi: 10.2165/00003495-200767140-00007. Drugs. 2007. PMID: 17883288 Review.
• [Treatment of tuberculosis according to the different pattern of resistance].

  Caminero JA. Caminero JA. Med Clin (Barc). 2010 Feb 13;134(4):173-81. doi: 10.1016/j.medcli.2008.12.024. Epub 2009 Apr 8. Med Clin (Barc). 2010. PMID: 19359015 Review. Spanish.